AKT1 and colorectal cancer: In conclusion, RA can effectively inhibit the growth of the colorectal cancer cell line HCT116 both in vitro and in vivo; this antitumor efficiency is likely to be achieved through the induction of apoptosis and cycle arrest, which occurs via regulation of the PI3K/AKT pathway.